There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine whether the OraQuick® HIV-1/2 Assay (OraSure Technologies, Inc., Bethlehem,
PA, USA) in sputum is a valid tool for HIV surveillance among TB patients.